Clinical Pharmaceutical Applications and Bioactivity of Furan-Containing Compounds: A Mini Review

Introduction

A common five-membered aromatic ring in pharmacologically active substances is furan (Figure 1). Its biological actions are highlighted in this review, along with its importance in contemporary medication development and discovery. It functions as a bioisostere for phenyl rings, providing modified steric and electronic characteristics that can improve metabolic stability, drug-receptor interactions, and bioavailability in general. Numerous medications from various therapeutic classifications, such as antimicrobials, anticancer medicines, anti-inflammatory treatments, and more, include the furan ring¹. Medicinal chemistry is based on heterocyclic compounds, with furan, a five-membered aromatic ring with one oxygen atom, being a crucial scaffold in a variety of physiologically active chemicals. The furan ring, which is found naturally in several essential oils and synthetic derivatives, is well-known for its straightforward structure, adaptability in chemistry, and capacity to improve pharmacological profiles when added to medicinal molecules.

The various therapeutic potentials of furan-based compounds, such as their antibacterial, antifungal, anticancer, antiviral, and anti-inflammatory qualities, have drawn attention in recent years. The furan ring’s capacity to engage in hydrogen bonding, π–π stacking, and other chemical interactions essential for target receptor binding is frequently credited with these biological activities^2,3. The importance of the furan ring in the creation of pharmaceutical drugs is examined in this paper, with particular attention to how it affects biological activity. The objective is to demonstrate the usefulness of furan derivatives in drug design and to pinpoint prospective avenues for further study by examining current developments and structure-activity correlations (SAR).

Figure 1: Chemical Structure Furan Click here to View Figure

Methodology

This review was conducted through a structured literature survey focusing on the pharmacological relevance of furan and its derivatives. The methodology involved literature search. Recent scientific articles published between 2010 and 2024 were collected from databases such as PubMed, Scopus, ScienceDirect, and Google Scholar. Keywords used included: “furan biological activity”, “furan derivatives pharmacology”, “furan medicinal chemistry”, and “heterocyclic drugs with furan”. Articles were selected based on their relevance to the topic, emphasis on furan-containing compounds, and experimental or clinical data supporting biological activities. Only synthetically occurring furan derivatives and their clinical relevance was evaluated based on reported pharmacological activities and potential therapeutic applications were considered.

Structural and Chemical Properties of the Furan Ring

Aromaticity

Despite having only one oxygen atom, furan exhibits aromaticity due to delocalized electrons ⁴.

Electron-rich nature

The lone pair of electrons on oxygen makes the ring highly reactive in electrophilic substitution reactions⁴.

Metabolic liability

Furan rings can undergo oxidation in vivo, sometimes leading to toxic metabolites—this is both a design consideration and a point of pharmacological interest ⁴ (Figure 2).

Figure 2: Properties of the Furan Ring Click here to View Figure

Chemical Structure and Role of Furan Ring

Nitrofurantoin contains a furan ring substituted with a nitro group and a hydantoin moiety. The furan ring is central to the drug’s electron transfer and antimicrobial activity. The nitro group undergoes reductive activation in bacterial cells, producing reactive intermediates. These intermediates interact with bacterial DNA and ribosomal proteins, causing lethal damage. The furan ring acts as a scaffold that facilitates this bioactivation and proper positioning of functional groups⁵. Inside bacterial cells, the nitro group on the furan ring is reduced by flavoproteins to highly reactive intermediates ^6,7.

Biological Activities of Furan Derivatives

Because of the ring’s capacity for both polar and non-polar interactions, molecules containing furan display a broad variety of biological functions. Strong pharmacological these show effects ⁹  compounds in a number of therapeutic domains, including antidepressant, anti-inflammatory, antibacterial, and anticancer properties. Structural changes at strategic locations on the furan ring, which affect receptor binding and metabolic stability, are frequently connected to their effectiveness ⁸. The furan nucleus is a useful scaffold in contemporary medication design and development because of its adaptability ^9,10. The biological potential of furan derivatives has expanded with the discovery of new therapeutic applications in recent studies^11-13 (Table 1).

Table 1: Biological Activities & Pharmacological Roles of Furan-containing Derivatives & Molecules

Structure-Activity Relationship (SAR)

Comparing furan-containing compounds to medications that are utilized in clinical settings helps to better understand their structure–activity relationship (SAR). For example, the nitrofuran ring found in nitrofurantoin, an antibiotic used to treat urinary tract infections(UTIs), is crucial to its antibacterial action because it causes bacteria to break their DNA. Similar to this, rofecoxib, a selective COX-2 inhibitor that was once used to treat inflammation and pain, has a furanone ring that is essential for enzyme binding. These illustrations show how the furan ring affects both biological activity and possible medical applications. Substitutions on the 2- and 5-positions of the furan ring are often crucial for activity. Electron-withdrawing groups (like nitro) increase bioactivity in antibacterial and anticancer contexts. Furan can mimic phenyl rings but offers distinct hydrophilic-lipophilic balance, useful in drug optimization. The furan nucleus is a five-membered aromatic heterocycle with one oxygen atom, providing both hydrophobic and polar character. Electrophilic substitutions typically occur at the 2-position, due to electron-rich nature¹⁴. The ether oxygen contributes to hydrogen bond acceptor capacity, enhancing interactions with biological targets. Modifications at 2-, 3-, and 5-positions of furan significantly alter activity (e.g., nitro, hydroxyl, or alkyl substituents). Attaching side chains (e.g., amines, alkyls, sulfonamides) modulates solubility, receptor affinity, and bioavailability.Moreover fused furan rings (e.g., benzofurans) often improve receptor binding and lipophilicity, affecting CNS activity ¹⁵ (Table 2).

Table 2: Structure-Activity Relationship (SAR) of furan-containing molecules

Clinical Toxicological Aspect of Furan

Despite its pharmacological activity, the furan ring can oxidize to form harmful metabolites, such as dialdehydes and epoxides. For example, several drugs containing furan have demonstrated hepatotoxicity in animal experiments. To reduce toxicity, medicinal chemists frequently alter the ring or employ bioisosteres. Despite these reservations, when taken as prescribed and closely watched, the clinical advantages of many medications containing furan greatly exceed any possible hazards ^16,17. Thus, furan is a potentially harmful compound with hepatotoxic and carcinogenic effects ^18-20, especially with chronic exposure.

Conclusion

Despite its pharmacological activity, the furan ring can oxidize to form harmful metabolites, such as dialdehydes and epoxides. For example, several drugs containing furan have demonstrated hepatotoxicity in animal experiments. To reduce toxicity, medicinal chemists frequently alter the ring or employ bioisosteres. Despite these reservations, when taken as prescribed and closely watched, the clinical advantages of many medications containing furan greatly exceed any possible hazards.

Acknowledgement

The authors extend their sincere appreciation to Asso. Prof. Dr. Weiam A. Hussein-Hail University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, for her help and support.

Funding Sources

The author(s) received no financial support for the research, authorship, and/or publication of this article.

Conflict of Interest

The author(s) do not have any conflict of interest.

Data Availability Statement

This statement does not apply to this article.

Ethics Statement

This research did not involve human participants, animal subjects, or any material that requires ethical approval.

Refernces

1. Manna, S. K., Giri, S., Mondal, S., Sana, R. N., Samal, A. K., & Mandal, A. A Detailed Review on C‐Fused Furan/3, 4‐Fused Furan Analog and its Potential Applications. ChemistrySelect, 2023, 8(1), e202203150.
   CrossRef
2. Thakur, A., & Ansari, A. Synthesis of Five-Membered Heterocyclic Compounds and Their Anticorrosive, Thermal, Electron Transfer, and Biological Properties. In Biennial International Conference on Future Learning Aspects of Mechanical Engineering, 2022,(pp. 247-261). Singapore: Springer Nature Singapore.
   CrossRef
3. De Coen, L. M., Heugebaert, T. S., Garcia, D., & Stevens, C. V. Synthetic entries to and biological activity of pyrrolopyrimidines. Chemical Reviews, 2016, 116(1), 80-139.
   CrossRef
4. Li, J. J. (Ed.). Heterocyclic chemistry in drug discovery. 2013, John Wiley & Sons.
5. Gandini, A. The behaviour of furan derivatives in polymerization reactions. In Polymer Chemistry: ESR Spectroscopy in Polymer Research, 2005, (pp. 47-96). Berlin, Heidelberg: Springer Berlin Heidelberg.
   CrossRef
6. Horner, K. E., & Karadakov, P. B. Chemical bonding and aromaticity in furan, pyrrole, and thiophene: a magnetic shielding study. The Journal of organic chemistry, 2013, 78(16), 8037-8043.
   CrossRef
7. Peterson, L. A. Reactive metabolites in the biotransformation of molecules containing a furan ring. Chemical research in toxicology, 2013, 26(1), 6-25.
   CrossRef
8. Saeid, H., Al-sayed, H., & Bader, M. A review on biological and medicinal significance of furan. AlQalam Journal of Medical and Applied Sciences, 2023, 44-58.
9. Pour, M., Špulák, M., Buchta, V., Kubanová, P., Vopršalová, M., Wsól, V., … & Schiller, R. 3-phenyl-5-acyloxymethyl-2 H, 5H-furan-2-ones: synthesis and biological activity of a novel group of potential antifungal drugs. Journal of medicinal chemistry, 2021, 44(17), 2701-2706.
   CrossRef
10. Saito, Y., Kishimoto, M., Yoshizawa, Y., & Kawaii, S. Synthesis and structure–activity relationship studies of furan-ring fused chalcones as antiproliferative agents. Anticancer Research, 2015, 35(2), 811-817.
11. Kevin, K.C., Liua Subas, M., Sakyab Christopher, J. O’Donnellb Andrew, C. Flickb, Jin., Li. Synthetic approaches to the 2009 new drugs, Bioorganic & Medicinal Chemistry, 2011, 19(3): 1136–1154.
    CrossRef
12. Dale, K.M., White, C.M. Dronedarone: an amiodarone analog for the treatment of atrial fibrillation and atrial flutter. Ann Pharmacother., 2007, 41 (4): 599–605.
    CrossRef
13. Dalligna, O.P., Porciúncula, L.O., Souza, D.O., Cunha, R.A., Lara, D.R., Dall’lgna, O.P. Neuroprotection by caffeine and adenosine A2A receptor blockade of beta-amyloid neurotoxicity. British journal of pharmacology, 2003, 138 (7): 1207–9.
    CrossRef
14. Daniel Lednicer, Lester A Mitscher, Gunda I Georg. The organic chemistry of drug synthesis. A Wiley- Interscience Publication, John Wiley & Sons, Inc. New York. 1990, 4: 5.
15. Banerjee, R., Kumar, H. K. S., & Banerjee, M. Medicinal significance of furan derivatives: a review. Int. J. Rev. Life Sci, 2012, 2(1), 7-16.
16. Alizadeh, M., Jalal, M., Hamed, K., Saber, A., Kheirouri, S., Pourteymour Fard Tabrizi, F., & Kamari, N. Recent updates on anti-inflammatory and antimicrobial effects of furan natural derivatives. Journal of Inflammation Research, 2020, 451-463.
    CrossRef
17. Han, Y., Cheng, S., Guo, F., Xiong, J., & Ji, L. Mechanistic and predictive studies on the oxidation of furans by cytochrome P450: A DFT study. Ecotoxicology and Environmental Safety, , 2024, 279, 116460.
    CrossRef
18. Bakhiya, N., & Appel, K. E. Toxicity and carcinogenicity of furan in human diet. Archives of toxicology, 2010, 84, 563-578.
    CrossRef
19. Singh, A., Bhat, T. K., & Sharma, O. P. Clinical biochemistry of hepatotoxicity. Journal of Clinical Toxicology S, 2011, 4, 2161-0495.
20. Végh, R., Csóka, M., Sörös, C., & Sipos, L. Underexplored food safety hazards of beekeeping products: Key knowledge gaps and suggestions for future research. Comprehensive Reviews in Food Science and Food Safety, 2024, 23(5), e13404.
    CrossRef